pancreatic mass
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with pancreatic mass who are refered to EUS-FNA
Exclusion criteria
Exclusion criteria: Patients with pancreatic mass which we cannot detect by EUS Patients with severe ascites Patients with other fatal disease Patients who have risk of bleeding Patients who do not agree to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The adequacy rate in each group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gross visual assessment of specimen adequacy, accuracy rate of EUS-FNA and adequacy rates of each time in each endosonographer. | — |
Countries
Japan
Contacts
Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Department of Gastroenterology and Hepatology